Efficacy and safety of sofosbuvir–velpatasvir with or without ribavirin in HCV-infected Japanese patients with decompensated cirrhosis: an open-label phase 3 trial

por Takehara, Tetsuo, Sakamoto, Naoya, Nishiguchi, Shuhei, Ikeda, Fusao, Tatsumi, Tomohide, Ueno, Yoshiyuki, Yatsuhashi, Hiroshi, Takikawa, Yasuhiro, Kanda, Tatsuo, Sakamoto, Minoru, Tamori, Akihiro, Mita, Eiji, Chayama, Kazuaki, Zhang, Gulan, De-Oertel, Shampa, Dvory-Sobol, Hadas, Matsuda, Takuma, Stamm, Luisa M., Brainard, Diana M., Tanaka, Yasuhito, Kurosaki, Masayuki
Publicado 2018